Market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights are among the key offerings featured in The Business Research Company’s 2026 market reports, designed to deliver more actionable and strategically valuable research.
Pharmaceutical Intermediates Market Growth Outlook: How Much Bigger Will The Market Be By 2030?
The pharmaceutical intermediates market size has demonstrated significant expansion in recent years. Forecasts indicate it will expand from $34.95 billion in 2025 to $37.38 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.0%. This historical growth can be attributed to several factors, including the increasing pharmaceutical manufacturing capacity, the expansion of generic drug markets, a rising demand for bulk drug intermediates, growing investments in chemical synthesis, and the availability of a skilled workforce for chemical manufacturing.
The pharmaceutical intermediates market is projected to experience substantial growth over the coming years. This market is anticipated to reach $49.52 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.3%. This expansion during the forecast period can be attributed to several factors, including the increasing development of intricate drug molecules, the growing need for contract manufacturing services, the broadening of biotech drug pipelines, an escalating emphasis on sustainable synthesis routes, and the rising adoption of advanced process technologies. Key trends foreseen in this period involve a heightened demand for high-purity drug intermediates, the increasing outsourcing of intermediate production, an expansion in generic drug manufacturing, the growing utilization of specialized chemical intermediates, and a strong focus on optimizing processes and improving yield.
Request A Free Pharmaceutical Intermediates Market Sample From The Business Research Company:
How Is The Key Growth Driver Influencing The Pharmaceutical Intermediates Market?
The pharmaceutical intermediates market is anticipated to expand due to the rising volume of pharmaceutical drug production. Drug production involves the manufacturing of pharmaceutical substances, medications, or finished drugs. These complex pharmaceutical drugs necessitate a multi-step synthesis process. Pharmaceutical intermediates are defined as the chemical compounds generated during these intermediate stages of the manufacturing process. The development of increasingly complex and targeted drugs further contributes to this intricacy. For example, data from November 2023, provided by the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing the European pharmaceutical industry, indicated that total pharmaceutical production in Europe reached €390,000 million ($422,803 million) in 2023. This marks an increase from €363,300 million ($393,857 million) recorded in 2022. Consequently, this upward trend in pharmaceutical drug production is a primary catalyst for the expansion of the pharmaceutical intermediates market.
Pharmaceutical Intermediates Market Segmentation By Category: What Does The 2026 Report Cover?
The pharmaceutical intermediates market covered in this report is segmented –
1) By Product: Chemical Intermediate, Bulk Drug Intermediate, Other Products
2) By Category: Branded Drug Intermediate, Generic Drug Intermediate
3) By Application: Analgesics, Anti-Infective Drugs, Cardiovascular Drugs, Oral Antidiabetic Drugs, Antimicrobial Drugs, Other Applications
4) By End-User: Biotech And Pharma Companies, Research Institutions, Other End-Users
Subsegments:
1) By Chemical Intermediates: Key Starting Materials (KSMs), Advanced Intermediates, Chiral Intermediates, Heterocyclic Intermediates, Functionalized Building Blocks
2) By Bulk Drug Intermediates: Precursor Intermediates, Advanced Bulk Intermediates, Late-Stage Intermediates, Isolated Reaction Intermediates
3) By Other Products: Biopharmaceutical Process Intermediates, Fermentation-Derived Intermediates, Semi-Synthetic Drug Intermediates
How Are Industry Players Changing The Pharmaceutical Intermediates Market Landscape?
Leading firms within the pharmaceutical intermediates market are introducing novel product categories, such as API Intermediates, to boost their market profitability. API intermediates refer to chemical compounds crucial for the creation of active pharmaceutical ingredients (APIs). A notable example is Huateng Pharmaceutical Co. Ltd., a pharmaceutical company from China, which unveiled its new product line, Gastrointestinal API Intermediates, in October 2023. These specific intermediates serve as foundational components for the active pharmaceutical ingredients present in medications targeting the digestive system. Their application is essential for manufacturing drugs that address gastrointestinal conditions, encompassing laxatives, 5-HT3 receptor antagonists, H2-receptor antagonists, and proton pump inhibitors.
Pharmaceutical Intermediates Market Global Key Players And Competitive Overview
Major companies operating in the pharmaceutical intermediates market are BASF SE, Lonza Group AG, Evonik Industries AG, LANXESS AG, Arkema S.A., Solvay S.A., Mitsubishi Chemical Group Corporation, Sumitomo Chemical Co., Ltd., Toray Industries, Inc., Asahi Kasei Corporation, Aarti Industries Limited, Divi’s Laboratories Limited, PI Industries Limited, Jubilant Pharmova Limited, WuXi AppTec Co., Ltd., Cambrex Corporation, Siegfried Holding AG, DSM-Firmenich AG, Clariant AG, Sanofi S.A
Explore Comprehensive Pharmaceutical Intermediates Market Coverage In The Full Report:
Regional Analysis Of The Pharmaceutical Intermediates Market: Where Is The Industry Concentrated?
North America was the largest region in the pharmaceutical intermediates market in 2025. The regions covered in the pharmaceutical intermediates market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
